HCA Holdings (HCA) Tops Q4 EPS by 55c, Offers FY21 Guidance

HCA Holdings (NYSE: HCA) reported Q4 EPS of $4.13, $0.55 better than the analyst estimate of $3.58. Revenue for the quarter came in at $14.29 billion versus the consensus estimate of $13.99 billion.

GUIDANCE:

HCA Holdings sees FY2021 EPS of $12.10-$13.10, versus the consensus of $11.95. HCA Holdings sees FY2021 revenue of $53.5-55.5 billion, versus the consensus of $54.33 billion.

For earnings history and earnings-related data on HCA Holdings (HCA) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79